The company focuses on developing innovative genetic constructs that specifically target cancer cells, enabling them to self-identify and self-destruct. Their approach aims to revolutionize early cancer detection and treatment, making the experience of cancer less severe by catching it at its earliest stages. They collaborate with various partners to enhance their technology and have received significant funding to advance their mission.
Cincinnati, Ohio
This organization specializes in providing comprehensive clinical research services, particularly for biopharmaceutical companies. It offers a full range of services including clinical trial management, regulatory affairs, medical writing, and laboratory services. The company focuses on accelerating the development of medical therapeutics through a collaborative model that integrates various specialties and expertise. Its operations span multiple therapeutic areas, ensuring tailored solutions for diverse clinical needs.
Pleasanton, California
This business specializes in providing advanced genomic tools and technologies that enable researchers to conduct high-quality single-cell analysis and spatial genomics. Their products, such as the Chromium platform and Visium Spatial, allow for detailed transcriptomic profiling and spatial mapping of gene expression, facilitating significant advancements in biological research and healthcare. They target scientists and researchers in the life sciences industry, offering innovative solutions that enhance research capabilities while reducing costs.
New York, NY
This business focuses on the development of RNA therapeutics using advanced technologies such as Artificial Intelligence and Machine Learning. Their proprietary SpliceCore® software platform enhances the discovery of drug targets by analyzing RNA sequencing data, allowing for faster and more precise identification of therapeutic targets. The platform is particularly adept at detecting splicing variations, which are critical for developing effective RNA-based therapies. Additionally, they have a specialized branch, SpliceIO™, that targets tumor-specific neoepitopes for immunotherapy applications.
This business specializes in AI-driven genomics software that provides accurate analysis of whole genomes, exomes, and gene panels. It serves clinical labs, hospital systems, and country sequencing programs by offering solutions for hereditary risk screening, rare disease diagnosis, and rapid NICU testing. The company focuses on automating genomic testing workflows to generate physician-ready clinical reports efficiently, thereby facilitating the implementation of precision medicine.
This business operates a platform that analyzes RNA to detect diseases, monitor health, and develop next-generation RNA therapeutics. Their OneRNA® platform allows for the repurposing of approved drugs tailored to individual patients and aims to expedite the development of novel RNA therapies. The focus is on cancer treatment, particularly breast and ovarian cancers, utilizing comprehensive RNA analysis to inform treatment decisions and improve patient outcomes.
Emeryville, California
This business focuses on developing innovative gene editing tools derived from natural microbial environments to create potentially curative genetic medicines. By leveraging metagenomics and artificial intelligence, they aim to discover and engineer novel genome editing systems that can precisely target any site in the human genome, addressing various devastating diseases with high efficiency and specificity.
Vancouver, WA
This company specializes in biologics drug discovery, utilizing generative AI to create novel antibodies and biologics therapies. Their innovative approach allows for the design of antibodies from scratch, bypassing traditional methods that rely on existing libraries. By integrating AI with synthetic biology, they aim to streamline the drug creation process, reduce development timelines, and improve success rates in bringing new therapies to patients, particularly for challenging diseases.
Seattle, WA
This business focuses on harnessing the power of the adaptive immune system to develop innovative diagnostic and therapeutic solutions. It offers a range of services including immune medicine platform development, clinical testing, and drug discovery, specifically targeting minimal residual disease (MRD) assessment and T-cell receptor therapeutics. The company aims to transform disease detection and treatment through advanced immune receptor data and technology.
San Diego, CA
This business specializes in the development of 3D human tissues for drug discovery and therapeutic applications. It focuses on creating innovative solutions that enhance the drug development process, particularly in the areas of inflammatory bowel disease and other medical conditions. The company targets pharmaceutical and biotechnology industries, providing them with advanced tissue models that can improve the efficacy and safety of drug candidates.
This company is focused on developing innovative cell therapies aimed at treating various forms of cancer. They specialize in creating invariant T cells as a new standard in cancer treatment, emphasizing the development of universal allogeneic cell therapies. The team consists of experts in biology, immunology, and cell therapy, working towards programmable living therapeutics.
San Francisco, CA
This business leverages artificial intelligence to enhance drug discovery processes, focusing on the development of new small molecule medicines. It operates a pipeline of wholly owned and co-developed assets, supported by significant investments. The company emphasizes the integration of advanced machine learning techniques, particularly convolutional neural networks, with extensive chemical libraries to address complex challenges in drug discovery.
Boston, MA
This business specializes in providing dog DNA testing services that help pet owners understand their dog's breed, health, and traits. They offer a range of products including breed identification tests, health screenings, and supplements aimed at improving canine health. Their services are targeted towards dog owners, breeders, and veterinary practices, providing insights that can enhance the care and management of dogs based on genetic information.
This service provides comprehensive genetic testing for dogs, helping owners and breeders understand their pets' health and genetic traits. It offers various tests that screen for genetic disorders, physical traits, and genetic diversity, enabling informed breeding decisions. The service is backed by extensive genetic research and aims to enhance the well-being of dogs through accurate and reliable testing.
California, US
This business operates in the biotechnology sector, focusing on advanced optical imaging technologies that enhance the capabilities of physicians at the cellular level. It has been recognized for its innovative diagnostics solutions and has received multiple awards for technical achievement and business excellence. The company is notable for being one of the earliest biotech firms funded by a prominent startup accelerator.
This business is focused on developing a new class of epigenetic medicines aimed at revolutionizing the treatment of genetically driven diseases. By leveraging the natural mechanisms of gene regulation, they aim to create genomic therapeutics that provide precise control over gene expression without altering the DNA sequence itself. Their approach is based on advanced research in the field of genomic medicine, promising durable and specific treatments.
This business specializes in advanced AI-powered technology designed to assist clinicians in planning and performing neurovascular surgeries. Their flagship product, PreSize® Neurovascular, allows users to create patient-specific blood vessel models from routine scans, enabling the selection of the best-fit implant devices before surgery. The technology aims to enhance surgical accuracy, reduce complications, and improve patient outcomes, while also engaging in clinical trials and research to validate its effectiveness.
This business specializes in advanced DNA sequencing technology, offering products such as library preparation kits and sequencing services. Their innovative solutions include TELL-Seq™ for long-read sequencing and AmpliDrop™ for single-cell sequencing. They cater to various applications including microbial genome sequencing, metagenome assembly, and whole genome phasing, targeting researchers and institutions in the genomics field.
South San Francisco, CA
This business specializes in AI-powered drug discovery, focusing on developing innovative treatments for significant medical challenges. Utilizing a proprietary multi-omics database derived from human tissue, the company employs machine learning to identify disease causes and create drug candidates. Their first drug targets amyotrophic lateral sclerosis (ALS) and they are also working on treatments for Parkinson's Disease and Frontotemporal Dementia.
Boston, MA
This biotechnology company focuses on curing blood cancers through innovative cell and genome engineering techniques. Their unique approach involves developing shielded transplants that allow for the delivery of potentially curative treatments after a stem cell transplant, specifically targeting acute myeloid leukemia (AML) and other blood cancers. The company utilizes a proprietary platform that integrates Hematopoietic Stem Cell (HSC) biology, genome engineering, and CAR-T cell technology to enhance treatment efficacy and reduce relapse rates.